Offidani, M. and Corvatta, L. (2017) “Elotuzumab: the first available immunotherapeutic arrow against relapsed-refractory Multiple Myeloma”, European Journal of Oncology and Environmental Health, 22(2), pp. 65–70. Available at: https://mail.mattioli1885journals.com/index.php/EJOEH/article/view/6857 (Accessed: 26 December 2024).